Koji Yoshida

IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND BIOAVAILABILITY OF ESTER PRODRUGS OF MGS0039 (3-(3,4-DICHLOROBENZYLOXY)-2-AMINO-6-FLUOROBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID), A POTENT METABOTROPIC GLUTAMATE RECEPTOR ANTAGONIST

A. Nakazato, Masato Nakamura, Y. Kawakita, 2006, Drug Metabolism and Disposition.

Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists.

M. Toda, T. Matsui, Shingo Yamamoto, 2006, Bioorganic & medicinal chemistry.

Effect of Calcium Reagents on Aldol Reactions of Phenolic Enolates with Aldehydes in Alcohol.

M. Morimoto, H. Saimoto, H. Sashiwa, 1996, The Journal of organic chemistry.

Synthesis and evaluation of a potent, well-balanced EP2/EP3 dual agonist.

A. Naganawa, M. Higashino, Hiroyuki Takeda, 2018, Bioorganic & medicinal chemistry.

Anthryl(alkylamino)cyclodextrin Complexes as Chemically Switched DNA Intercalators

H. Schneider, Koji Yoshida, T. Ikeda, 1995 .

Disposition and metabolism of [3H]gliclazide in rats

H. Suzuki, S. Arakawa, H. Miyazaki, 1983, European journal of drug metabolism and pharmacokinetics.

Synthesis of a Novel Class of Water-Soluble and Bioavailable Antioxidants: 5-Hydroxycoumaran Derivatives Possessing Imidazole Group

M. Kawamura, H. Tsuruta, Koji Yoshida, 1997 .

Identification of 2-[2-(4-tert-butylphenyl)ethyl]-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (29) as an orally available MGAT2 inhibitor.

N. Sato, E. Munetomo, K. Kitano, 2015, Bioorganic & medicinal chemistry.

Preparation and β-elimination of a 5-deoxy-5-nitromaltitol derivative: an approach to selective cleavage of the glycosidic bond at the reducing end of oligosaccharides

N. Kashimura, Koji Yoshida, K. Onodera, 1975 .